1.Clinical Effect of Procetofene(Lipanthyl(R)) on the Serum Lipids in the Hyperlipidemic Patients.
Yun Shik CHOI ; Jeong Sik PARK ; Jeongdon SEO ; Young Woo LEE
Korean Circulation Journal 1981;11(1):113-119
We observed the levels of serum cholesterol, triglyceride and HDL-cholesterol in 28-hyperlipidemic patients after treatment with procetofene(Lipanthyl(R)), a new hypolipidemic agent. The results were as follows. 1. The hyperlipidemic patients were 7 cases of pure hypercholesterolemia, 12 cases of mixed hyperlipidemia and 9 cases of pure hypertriglyceridemia. 2. All the patients were treated with daily dose of 200 to 400mg, usually 300mg, and duration of more than 12 weeks. 3. The serum cholesterol decreased significantly at the rate of 29% in pure hypercholes terolemia and 29% in mixed hyperlipidemia after treatment for 12 weeks. 4. The serum triglyceride decreased significantly at the rate of 58% in mixed hyperlipidemia and 42% in pure hypertriglyceridemia after treatment for 12 weeks. 5. The serum HDL-cholesterol increased at the rate of 10% in pure hypercholesterolemia, 14% in mixed hyperlipidemia and 26% in pure hypertriglyceridemia after treatment for 12 weeks, but the increase rate was statistically significant only in pure hypertriglyceridemia. 6. Transient epigastric discomfort was complained by 2 patients, but subsided spontaneously with continuous treatment. 7. In view of these results, procetofene appears to be an effective and well tolerated agent for the treatment of all the types of hyperlipidemia.
Cholesterol
;
Fenofibrate
;
Humans
;
Hypercholesterolemia
;
Hyperlipidemias
;
Hypertriglyceridemia
;
Triglycerides
2.A Clinical Study on Coenzyme Q10(Neuquinon(R)) in the Treatment of Congestive Heart Failure.
Jeong Hyun KIM ; Jong Yoon LIM ; Yun Shik CHOI ; Jung Don SEO ; Young Woo LEE
Korean Circulation Journal 1979;9(1):17-22
Coenzyme Q is concentrated in Golgi apparatus membranes and mitochondria, but not in other membranes. Although it is difficult to prove the metabolic action of coenzyme Q administered exogenously in clinical cases, the effect of this substance can be evaluated by criteria based on clinical findings. In an attempt to evaluate the effect of coenzyme Q for the treatment of 67 patients(male 26 cases, female 41 cases) of congestive heart failure, we administered Coenzyme Q1030mg daily for 4 to 8 weeks. Most of them were valvular heart disease(74.6%) and hypertension (14.9%). Clinical effects were evaluated at least 4 weeks later by the criteria using a scoring method of severity of congestive heart failure which was devised by Ishiyama, etc. In summary, a definite effect was found in 13 cases(19%) and a mild effect was observed in 46 cases(69%). During treatment there were no significant side effects, and also no significant changes in heart rate and blood pressure.
Blood Pressure
;
Estrogens, Conjugated (USP)*
;
Female
;
Golgi Apparatus
;
Heart
;
Heart Failure*
;
Heart Rate
;
Humans
;
Hypertension
;
Membranes
;
Mitochondria
;
Research Design
;
Ubiquinone
3.A Case of Beckwith-Wiedemann Syndrome.
Jeong Wi WOOK ; Eun Young CHOI ; Min Shik KIM ; Hey Sun LEE ; Young Min AHN
Journal of the Korean Pediatric Society 1988;31(12):1685-1688
No abstract available.
Beckwith-Wiedemann Syndrome*
4.Stomal Complications in Infants and Children.
Si Youl JUN ; Hyun Sheol CHOI ; Seok LEE ; Keuk Won JEONG ; Woo Shik CHUNG
Journal of the Korean Society of Coloproctology 1998;14(2):299-304
We performed this study to analyse the morbidity and mortality of stoma formation in infants and children over a 17-year period. Thirty-seven stoma formations were performed in 37 patients: 21 for anorectal malformation, 9 for Hirschsprung's disease, 3 for necrotizing enterocolitis, 2 for multiple ileal atresia, 1 for volvulus neonatorum with perforation, and 1 for diaphragmatic hernia with colon perforation. There were 26 boys and 11 girls with a mean age of 0.4 years. Complications after stoma formation were encountered in 12 patients(32.4%) and included stomal prolapse, stenosis, retraction, dysfunction, skin excoriation and parastomal hernia. Four patients(10.8%) required stomal revision. The incidence of complications was neither related to the age nor to the primary indication for the stoma formation, but sigmoid colostomy was associated with a lower complication rate compared to transverse colostomy(22.1% versus 42.1%, P<0.05). Five patients died, but only one(2.7%) was dead, which was directly related to stoma formation. Eighteen of these children subsequently underwent stoma closure which was associated with complications in six patients(33.3%). The most common complication after stoma closure was wound sepsis in 4 children. In conclusion, because the significant morbidity of stoma formation still exists the refinements in surgical technique may help in reducing the incidence of complications and a sigmoid loop colostomy should be used whenever possible.
Child*
;
Colon
;
Colon, Sigmoid
;
Colostomy
;
Constriction, Pathologic
;
Enterocolitis, Necrotizing
;
Female
;
Hernia
;
Hernia, Diaphragmatic
;
Hirschsprung Disease
;
Humans
;
Incidence
;
Infant*
;
Intestinal Volvulus
;
Mortality
;
Prolapse
;
Sepsis
;
Skin
;
Wounds and Injuries
5.Immediate and Follow-up Results after Percutaneous Mitral Valvuloplasty in Mitral Stenosis.
Myeong Chan CHO ; June Soo KIM ; Chee Jeong KIM ; Myoung Mook LEE ; Yun Shik CHOI ; Young Woo LEE
Korean Circulation Journal 1991;21(5):829-841
Percuaneous mitral valvuloplasty(PMV) is an alternative to surgical mitral commissurotomy for patients with mitral stenosis. To assess the immediate and follow-up results of PMV and to identify factors in fluencing the outcome and coplications of PMV, we analyzed the clinical, echocardiographic and hemodynamic data of 108 patients who underwent PMV. 1) Good hemodynamic results were obtained in 86 patients(79.6%). The factors predicting immediate outcome of PMV were mitral valve mobility, total echoscore, and EBDA/BSA. 2) Predictors of the increase in mitral valve area by PMV were age, sex, rhythm, and NYHA functional class before PMV. The independant predictors were rhythm(p=0.008) and functional class(p=0.002). 3) The degree of mitral regurgitation increased in 26 patients(24%), did not changed in 79 patients(73%) and decreased in 3 patients(3%). The increase of MR could not predicted from any features of the clinical, echocardiographic or hemodynamic daa. The severity of MR decreased by one grade in 15% of patients and did not change in 66% of patients during follow-up. 4) Left-to-right shunt was detected in 19 patients(18%). The predictors were valve mobility, pulmonary artery pressure and pulmonary vascular resistance. 5) Follow-up catheterization(mean 14 months) identified restenosis in six of 16 patients. The predictors of restenosis were sex, total echosecore, and left atrial volume. 6) The hemodynamic data at follow-up were good compared with prePMV data(p<0.01), but follow-up miral valve area decreased than that of postPMV(p<0.05). Immediate decrease in pulmonary vascular resistance followed by progressive improvement during follow-up. 7) Immediate complications of PMV were peripheral arterial embolism in one patient(1%), pericardial effusion in two(2%), transient arrhythmia in four(4%), left-to-right shunt in nineteen(18%) and increase in the grade of MR in twenty-six(24%). This study suggests, that PMV produces excellent immediate and follow-up results and is a safe and effective procedure in the nonsurgical treatment of mitral stenosis.
Arrhythmias, Cardiac
;
Echocardiography
;
Embolism
;
Follow-Up Studies*
;
Hemodynamics
;
Humans
;
Mitral Valve
;
Mitral Valve Insufficiency
;
Mitral Valve Stenosis*
;
Pericardial Effusion
;
Pulmonary Artery
;
Vascular Resistance
6.Immediate and Follow-up Results after Percutaneous Mitral Valvuloplasty in Mitral Stenosis.
Myeong Chan CHO ; June Soo KIM ; Chee Jeong KIM ; Myoung Mook LEE ; Yun Shik CHOI ; Young Woo LEE
Korean Circulation Journal 1991;21(5):829-841
Percuaneous mitral valvuloplasty(PMV) is an alternative to surgical mitral commissurotomy for patients with mitral stenosis. To assess the immediate and follow-up results of PMV and to identify factors in fluencing the outcome and coplications of PMV, we analyzed the clinical, echocardiographic and hemodynamic data of 108 patients who underwent PMV. 1) Good hemodynamic results were obtained in 86 patients(79.6%). The factors predicting immediate outcome of PMV were mitral valve mobility, total echoscore, and EBDA/BSA. 2) Predictors of the increase in mitral valve area by PMV were age, sex, rhythm, and NYHA functional class before PMV. The independant predictors were rhythm(p=0.008) and functional class(p=0.002). 3) The degree of mitral regurgitation increased in 26 patients(24%), did not changed in 79 patients(73%) and decreased in 3 patients(3%). The increase of MR could not predicted from any features of the clinical, echocardiographic or hemodynamic daa. The severity of MR decreased by one grade in 15% of patients and did not change in 66% of patients during follow-up. 4) Left-to-right shunt was detected in 19 patients(18%). The predictors were valve mobility, pulmonary artery pressure and pulmonary vascular resistance. 5) Follow-up catheterization(mean 14 months) identified restenosis in six of 16 patients. The predictors of restenosis were sex, total echosecore, and left atrial volume. 6) The hemodynamic data at follow-up were good compared with prePMV data(p<0.01), but follow-up miral valve area decreased than that of postPMV(p<0.05). Immediate decrease in pulmonary vascular resistance followed by progressive improvement during follow-up. 7) Immediate complications of PMV were peripheral arterial embolism in one patient(1%), pericardial effusion in two(2%), transient arrhythmia in four(4%), left-to-right shunt in nineteen(18%) and increase in the grade of MR in twenty-six(24%). This study suggests, that PMV produces excellent immediate and follow-up results and is a safe and effective procedure in the nonsurgical treatment of mitral stenosis.
Arrhythmias, Cardiac
;
Echocardiography
;
Embolism
;
Follow-Up Studies*
;
Hemodynamics
;
Humans
;
Mitral Valve
;
Mitral Valve Insufficiency
;
Mitral Valve Stenosis*
;
Pericardial Effusion
;
Pulmonary Artery
;
Vascular Resistance
7.Computer Simulation Surgery for Mandibular Reconstruction Using a Fibular Osteotomy Guide.
Woo Shik JEONG ; Jong Woo CHOI ; Seung Ho CHOI
Archives of Plastic Surgery 2014;41(5):584-587
In the present study, a fibular osteotomy guide based on a computer simulation was applied to a patient who had undergone mandibular segmental ostectomy due to oncological complications. This patient was a 68-year-old woman who presented to our department with a biopsy-proven squamous cell carcinoma on her left gingival area. This lesion had destroyed the cortical bony structure, and the patient showed attenuation of her soft tissue along the inferior alveolar nerve, indicating perineural spread of the tumor. Prior to surgery, a three-dimensional computed tomography scan of the facial and fibular bones was performed. We then created a virtual computer simulation of the mandibular segmental defect through which we segmented the fibular to reconstruct the proper angulation in the original mandible. Approximately 2-cm segments were created on the basis of this simulation and applied to the virtually simulated mandibular segmental defect. Thus, we obtained a virtual model of the ideal mandibular reconstruction for this patient with a fibular free flap. We could then use this computer simulation for the subsequent surgery and minimize the bony gaps between the multiple fibular bony segments.
Aged
;
Carcinoma, Squamous Cell
;
Computer Simulation*
;
Female
;
Free Tissue Flaps
;
Head and Neck Neoplasms
;
Humans
;
Mandible
;
Mandibular Nerve
;
Mandibular Reconstruction*
;
Osteotomy*
;
Surgery, Plastic
8.Effect of Bezafibrate(Bezalip(R))in Patients with Hyperlipidemia.
Chee Jeong KIM ; Young Dae KIM ; Dong Jin OH ; Byung Hee OH ; Myoung Mook LEE ; Young Bae PARK ; Yun Shik CHOI ; Jung Don SEO ; Young Woo LEE
Korean Circulation Journal 1989;19(3):497-502
41 patients with hyperlipidemia(Serum cholesterol > or =260mg% or triglyceride> or =200mg%) were treated for 12 weeks each with either Bezafibrate(200mg t.i.d.)(n=23) or placebo(n=18) in a randomized trial. Compared with placebo, Bezafibrate was more effective in lowing total cholesterol(287+/-63 to 244+/-32 mg%, P<0.01), LDL-cholesterol(183+/-39 to 153 +/-25mg%, P<0.01) and the LDL/HDL ratio(4.7+/-2.9 to 3.4+/-1.3, P<0.05). There was also a marked reduction in serum triglyceride(307+/-295 to 218+/-167mg%, P<0.05) as well as a significant increase in HDL-cholesterol(43+/-12 to 48+/-12mg%, P<0.05). Compliance or tolerance to both Bezafibrate and placebo was good. No significant side effects except one case, who complained of mild indigestion, were observed. Therefore, Bezafibrate seemed to be effective in lowing serum total cholesterol, LDL-cholestrol, triglyceride and in increasing in HDL-cholesterol without significant side effect.
Bezafibrate
;
Cholesterol
;
Compliance
;
Dyspepsia
;
Humans
;
Hyperlipidemias*
;
Triglycerides
9.A Case Report of Peutz - Jeghers' Syndrome Associated Anemia and Intussusception.
Young Gil LEE ; Chi Hong KIM ; Sang Wook CHOI ; Hwa Shik MOON ; Jin Wu JEONG ; Doo Ho PARK ; Boo Sung KIM ; Eun Joo SEO
Korean Journal of Gastrointestinal Endoscopy 1989;9(1):43-47
The Peutz-Jeghers syndrome has three cardinal features: gastrointestinal polypasis, mucocutaneous piginentation and autosomal dominant heredity. This syndrome is ciinically important because of the complication caused by the gastrointestinal ployp, leading to abdominal pain, gastrointestinal bleeding and intussusception. We experienced a case of Peutz-Jeghers syndrome who complained of dizziness, vague abdominal pain, melanin pigmentations of the lips, oral mucosa and digits and reported with the review of the literature.
Abdominal Pain
;
Anemia*
;
Dizziness
;
Hemorrhage
;
Heredity
;
Intussusception*
;
Lip
;
Melanins
;
Mouth Mucosa
;
Peutz-Jeghers Syndrome
;
Pigmentation
10.A case of anomalous left coronary artery from pulmonary artery (Bland-White-garland sysndrome).
Se Il O ; Ha Jin LIM ; Byung Hee OH ; Myoung Mook LEE ; Young Bae PARK ; Yun Shik CHOI ; Jung Don SEO ; Young Woo LEE ; Jeong Hyun KIM
Korean Circulation Journal 1993;23(3):468-473
An anomalous left coronary artery from the pulmonary artery(Bland-White-Garland syndrome) is a rare congenital malformation and sometimes fatal. It is caused by an abberant endothelial budding from or an anomalous division of the truncus arteriosus. Echocardiography (transthoracic and transesophageal) and angiographical imaging are essential for the diagnosis of this anomaly. Corrective Surgery is recommended due to its fatal natural course. A case was diagnosed in a 45-year-old man who presented with intermittent palpitation. This patient was successfully treated with closure of anomalous left coronary artery orifice combined with right saphenous vein graft anastomosis.
Bland White Garland Syndrome
;
Coronary Vessels*
;
Diagnosis
;
Echocardiography
;
Humans
;
Middle Aged
;
Pulmonary Artery*
;
Saphenous Vein
;
Transplants
;
Truncus Arteriosus